Hypopituitarism after Gamma Knife radiosurgery for pituitary adenomas: a multicenter, international study

Restricted access

OBJECTIVE

Recurrent or residual adenomas are frequently treated with Gamma Knife radiosurgery (GKRS). The most common complication after GKRS for pituitary adenomas is hypopituitarism. In the current study, the authors detail the timing and types of hypopituitarism in a multicenter, international cohort of pituitary adenoma patients treated with GKRS.

METHODS

Seventeen institutions pooled clinical data obtained from pituitary adenoma patients who were treated with GKRS from 1988 to 2016. Patients who had undergone prior radiotherapy were excluded. A total of 1023 patients met the study inclusion criteria. The treated lesions included 410 nonfunctioning pituitary adenomas (NFPAs), 262 cases of Cushing’s disease (CD), and 251 cases of acromegaly. The median follow-up was 51 months (range 6–246 months). Statistical analysis was performed using a Cox proportional hazards model to evaluate factors associated with the development of new-onset hypopituitarism.

RESULTS

At last follow-up, 248 patients had developed new pituitary hormone deficiency (86 with NFPA, 66 with CD, and 96 with acromegaly). Among these patients, 150 (60.5%) had single and 98 (39.5%) had multiple hormone deficiencies. New hormonal changes included 82 cortisol (21.6%), 135 thyrotropin (35.6%), 92 gonadotropin (24.3%), 59 growth hormone (15.6%), and 11 vasopressin (2.9%) deficiencies. The actuarial 1-year, 3-year, 5-year, 7-year, and 10-year rates of hypopituitarism were 7.8%, 16.2%, 22.4%, 27.5%, and 31.3%, respectively. The median time to hypopituitarism onset was 39 months.

In univariate analyses, an increased rate of new-onset hypopituitarism was significantly associated with a lower isodose line (p = 0.006, HR = 8.695), whole sellar targeting (p = 0.033, HR = 1.452), and treatment of a functional pituitary adenoma as compared with an NFPA (p = 0.008, HR = 1.510). In multivariate analyses, only a lower isodose line was found to be an independent predictor of new-onset hypopituitarism (p = 0.001, HR = 1.38).

CONCLUSIONS

Hypopituitarism remains the most common unintended effect of GKRS for a pituitary adenoma. Treating the target volume at an isodose line of 50% or greater and avoiding whole-sellar radiosurgery, unless necessary, will likely mitigate the risk of post-GKRS hypopituitarism. Follow-up of these patients is required to detect and treat latent endocrinopathies.

ABBREVIATIONS ACTH = adrenocorticotropic hormone; CD = Cushing’s disease; DI = diabetes insipidus; FPA = functioning pituitary adenoma; FSH = follicle-stimulating hormone; GH = growth hormone; GKRS = Gamma Knife radiosurgery; IGF-1 = insulin-like growth factor–1; IGKRF = International Gamma Knife Research Foundation; NFPA = nonfunctioning pituitary adenoma; QOL = quality of life; RT = radiation therapy; SRS = stereotactic radiosurgery; TSH = thyroid-stimulating hormone; T4 = free thyroxin.

Article Information

Correspondence Jason P. Sheehan: University of Virginia Health System, Charlottesville, VA. jsheehan@virginia.edu.

INCLUDE WHEN CITING Published online November 9, 2018; DOI: 10.3171/2018.5.JNS18509.

Disclosures Dr. Lunsford reports being a consultant for Insightec DSMB and having direct stock ownership in Elekta. Dr. Grills reports having direct stock ownership in Greater Michigan Gamma Knife, where she is on the executive board of directors, and she reports receiving, through her institution, research funding from Elekta that is unrelated to the present study.

© AANS, except where prohibited by US copyright law.

Headings

Figures

  • View in gallery

    New hormone deficiencies in patients with different types of adenoma.

  • View in gallery

    Kaplan-Meier plot of time to new-onset hypopituitarism related to NFPA and FPA.

  • View in gallery

    Kaplan-Meier plot of time to new-onset hypopituitarism in relation to the isodose line prescription.

References

  • 1

    Ahmed SElsheikh MStratton IMPage RCAdams CBWass JA: Outcome of transphenoidal surgery for acromegaly and its relationship to surgical experience. Clin Endocrinol (Oxf) 50:5615671999

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 2

    Castinetti FRégis JDufour HBrue T: Role of stereotactic radiosurgery in the management of pituitary adenomas. Nat Rev Endocrinol 6:2142232010

  • 3

    Cushing H: The Pituitary Body and its Disorders. Clinical States Produced by Disorders of the Hypophysis Cerebri. Philadelphia: J.B. Lippincott1912

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4

    Darzy KH: Radiation-induced hypopituitarism after cancer therapy: who, how and when to test. Nat Clin Pract Endocrinol Metab 5:88–992009

  • 5

    Darzy KHShalet SM: Hypopituitarism following radiotherapy revisited. Endocr Dev 15:1–242009

  • 6

    Dekkers OMPereira AMRoelfsema FVoormolen JHNeelis KJSchroijen MA: Observation alone after transsphenoidal surgery for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 91:179618012006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 7

    Dekkers OMPereira AMRomijn JA: Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J Clin Endocrinol Metab 93:371737262008

  • 8

    Ezzat SAsa SLCouldwell WTBarr CEDodge WEVance ML: The prevalence of pituitary adenomas: a systematic review. Cancer 101:6136192004

  • 9

    Fatemi NDusick JRMattozo CMcArthur DLCohan PBoscardin J: Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery 63:7097192008

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 10

    Feigl GCBonelli CMBerghold AMokry M: Effects of gamma knife radiosurgery of pituitary adenomas on pituitary function. J Neurosurg 97 (5 Suppl):4154212002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 11

    Feigl GCPistracher KBerghold AMokry M: Pituitary insufficiency as a side effect after radiosurgery for pituitary adenomas: the role of the hypothalamus. J Neurosurg 113 Suppl:1531592010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 12

    Gopalan RSchlesinger DVance MLLaws ESheehan J: Long-term outcomes after Gamma Knife radiosurgery for patients with a nonfunctioning pituitary adenoma. Neurosurgery 69:2842932011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 13

    Höybye CRähn T: Adjuvant Gamma Knife radiosurgery in non-functioning pituitary adenomas; low risk of long-term complications in selected patients. Pituitary 12:2112162009

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 14

    Jane JA JrVance MLWoodburn CJLaws ER Jr: Stereotactic radiosurgery for hypersecreting pituitary tumors: part of a multimodality approach. Neurosurg Focus 14(5):e122003

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 15

    Jasim SAlahdab FAhmed ATTamhane SProkop LJNippoldt TB: Mortality in adults with hypopituitarism: a systematic review and meta-analysis. Endocrine 56:33422017

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 16

    Johnson MDWoodburn CJVance ML: Quality of life in patients with a pituitary adenoma. Pituitary 6:81872003

  • 17

    Lee CCChen CJYen CPXu ZSchlesinger DFezeu F: Whole-sellar stereotactic radiosurgery for functioning pituitary adenomas. Neurosurgery 75:2272372014

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 18

    Leenstra JLTanaka SKline RWBrown PDLink MJNippoldt TB: Factors associated with endocrine deficits after stereotactic radiosurgery of pituitary adenomas. Neurosurgery 67:27–332010

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 19

    Leksell L: The stereotaxic method and radiosurgery of the brain. Acta Chir Scand 102:3163191951

  • 20

    Lindholm JNielsen EHBjerre PChristiansen JSHagen CJuul S: Hypopituitarism and mortality in pituitary adenoma. Clin Endocrinol (Oxf) 65:51–582006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 21

    Littley MDShalet SMBeardwell CGAhmed SRApplegate GSutton ML: Hypopituitarism following external radiotherapy for pituitary tumours in adults. Q J Med 70:1451601989

    • PubMed
    • Search Google Scholar
    • Export Citation
  • 22

    Lloyd RVOsamura RYKloppel GRosai J (eds): WHO Classification of Tumours of Endocrine Organs ed 4. Lyon, France: International Agency for Research on Cancer2017

    • Search Google Scholar
    • Export Citation
  • 23

    Lopes MBS: The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. Acta Neuropathol 134:5215352017

  • 24

    Minniti GJaffrain-Rea MLOsti MCantore GEnrici RM: Radiotherapy for nonfunctioning pituitary adenomas: from conventional to modern stereotactic radiation techniques. Neurosurg Rev 30:1671762007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 25

    Nomikos PBuchfelder MFahlbusch R: The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical ‘cure’. Eur J Endocrinol 152:3793872005

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 26

    Nomikos PLadar CFahlbusch RBuchfelder M: Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas—a study on 721 patients. Acta Neurochir (Wien) 146:27–352004

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 27

    Petrovich ZYu CGiannotta SLZee CSApuzzo ML: Gamma knife radiosurgery for pituitary adenoma: early results. Neurosurgery 53:51612003

  • 28

    Pollock BEJacob JTBrown PDNippoldt TB: Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg 106:8338382007

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 29

    Pollock BENippoldt TBStafford SLFoote RLAbboud CF: Results of stereotactic radiosurgery in patients with hormone-producing pituitary adenomas: factors associated with endocrine normalization. J Neurosurg 97:5255302002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 30

    Regal MPáramo CSierra SMGarcia-Mayor RV: Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain. Clin Endocrinol (Oxf) 55:7357402001

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 31

    Sheehan JPKondziolka DFlickinger JLunsford LD: Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97 (5 Suppl):4084142002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 32

    Sheehan JPNiranjan ASheehan JMJane JA JrLaws ERKondziolka D: Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102:6786912005

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 33

    Sheehan JPPouratian NSteiner LLaws ERVance ML: Gamma Knife surgery for pituitary adenomas: factors related to radiological and endocrine outcomes. J Neurosurg 114:3033092011

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 34

    Shiue KBarnett GHSuh JHVogelbaum MAReddy CAWeil RJ: Using higher isodose lines for gamma knife treatment of 1 to 3 brain metastases is safe and effective. Neurosurgery 74:3603662014

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 35

    Snell JWSheehan JStroila MSteiner L: Assessment of imaging studies used with radiosurgery: a volumetric algorithm and an estimation of its error. Technical note. J Neurosurg 104:1571622006

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 36

    Toogood AA: Endocrine consequences of brain irradiation. Growth Horm IGF Res 14 (Suppl A):S118S1242004

  • 37

    Vance ML: Hypopituitarism. N Engl J Med 330:165116621994

  • 38

    Webb SMCrespo ISantos AResmini EAulinas AValassi E: Management of endocrine disease: quality of life tools for the management of pituitary disease. Eur J Endocrinol 177:R13R262017

    • Search Google Scholar
    • Export Citation
  • 39

    Witt TC: Stereotactic radiosurgery for pituitary tumors. Neurosurg Focus 14(5):e102003

  • 40

    Wowra BStummer W: Efficacy of gamma knife radiosurgery for nonfunctioning pituitary adenomas: a quantitative follow up with magnetic resonance imaging-based volumetric analysis. J Neurosurg 97 (5 Suppl):4294322002

    • Crossref
    • PubMed
    • Search Google Scholar
    • Export Citation
  • 41

    Xu ZLee Vance MSchlesinger DSheehan JP: Hypopituitarism after stereotactic radiosurgery for pituitary adenomas. Neurosurgery 72:6306372013

TrendMD

Metrics

Metrics

All Time Past Year Past 30 Days
Abstract Views 737 737 17
Full Text Views 292 292 1
PDF Downloads 91 91 0
EPUB Downloads 0 0 0

PubMed

Google Scholar